Welcome to our dedicated page for Cognex SEC filings (Ticker: CGNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cognex Corporation (CGNX) SEC filings page on Stock Titan aggregates the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, providing a structured view of how this industrial machine vision issuer reports its financial and corporate information. Cognex is incorporated in Massachusetts and files under Commission File Number 001-34218, with its common stock listed on NASDAQ under the symbol CGNX.
Among the key documents available are Form 10-K annual reports and Form 10-Q quarterly reports, where Cognex discusses its machine vision business, risk factors, and financial statements. These filings are important for understanding trends in logistics and factory automation demand, as well as the company’s investment in AI-enabled vision products, as referenced in its public communications.
Investors will also find Form 8-K current reports that Cognex uses to announce material events. Recent 8-K filings include the release of quarterly financial results, dividend declarations, and an audit firm rotation in which the Audit Committee selected KPMG LLP as the independent registered public accounting firm for a future fiscal year, following Grant Thornton LLP. Such filings provide timely insight into corporate actions and governance decisions.
On this page, users can monitor real-time updates from EDGAR, including 8-Ks, 10-Qs, 10-Ks, and other forms that Cognex may file. Stock Titan’s tools offer AI-powered summaries that help explain the contents of lengthy filings, highlight key sections, and clarify technical language around accounting, risk disclosures, and strategic priorities. In addition, Form 4 insider transaction reports, when filed, can be accessed to review share transactions by Cognex officers, directors, or significant shareholders.
By using the CGNX filings page, investors and researchers can quickly move from raw SEC documents to clearer explanations of how Cognex presents its financial condition, machine vision strategy, and corporate developments in official filings.
COGNEX CORP executive Mark Fennell, Chief Legal Officer & Secretary, has filed an initial ownership report showing his equity position in the company. He directly holds 4,863 shares of common stock, along with several blocks of restricted stock units and non-qualified stock options tied to Cognex common shares.
COGNEX CORP vice president Darren Marc Long filed a Form 3 showing his current equity stake in the company. He directly holds 5,569 shares of common stock, plus multiple restricted stock units and non-qualified stock options over Cognex common stock with various exercise prices and expiration dates.
Cognex Corp vice president Michael Bowdoin filed an initial ownership report showing he directly holds 11,139 shares of common stock. He also reports multiple restricted stock units that can convert into common shares, and several non-qualified stock options with exercise prices ranging from $33.04 to $90.50 per share and expirations extending through 2036.
Cognex Corporation reported governance updates from its 2026 annual meeting and a change in officer status. The board determined that Joerg Kuechen will no longer be treated as an “executive officer” under Exchange Act rules, and he will remain with the company as Head of Mergers and Acquisitions.
At the meeting, shareholders representing 153,890,280 of 167,013,856 shares outstanding as of the record date approved all proposals recommended by the board. Three directors—Matthew Moschner, Angelos Papadimitriou and Christopher Donato—were elected to terms ending in 2029. Shareholders also approved an amendment to the 2023 Stock Option and Incentive Plan, ratified KPMG LLP as independent registered public accounting firm for fiscal 2026, and gave advisory approval to executive compensation as described in the proxy statement.
Cognex Corp reported that Vanguard Capital Management disclosed beneficial ownership of 8,705,689 shares of Common Stock, representing 5.21% of the class. The filing states Vanguard has sole dispositive power over 8,705,689 shares and sole voting power for 1,275,533 shares. The filing is a Schedule 13G disclosure signed on 04/29/2026 and describes holdings held on behalf of Vanguard-managed funds and accounts.
Cognex Corp reports a Schedule 13G showing Vanguard Portfolio Management beneficially owns 10,390,950 shares of Common Stock. The filing states this equals 6.22% of the class and attributes dispositive power to Vanguard Portfolio Management LLC and affiliated business divisions. The filing lists 20,303 shares of sole voting power and affirms holdings are managed on behalf of multiple clients.
The Vanguard Group files an amendment stating it holds 0 shares (0%) of Cognex Corp common stock. The filing notes an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries to report holdings separately. The statement is signed by Ashley Grim, Head of Global Fund Administration on 03/26/2026.
COGNEX CORP director Christopher Donato filed an initial Form 3, which records his status as a reporting insider of the company. The filing reports no purchases, sales, or other transactions in Cognex stock, serving only as a baseline disclosure of his insider position.
COGNEX CORP director Sami Atiya filed an initial insider ownership report on the company’s stock. The filing is a Form 3, which establishes Atiya’s status as a director and provides a baseline disclosure of insider holdings. It reports no purchases, sales, exercises, gifts, or other transactions.
Cognex Corp VP and principal accounting officer Laura Ann MacDonald reported routine equity compensation activity. On March 15, 2026 she exercised 368 restricted stock units, receiving an equal number of common shares. Of these, 109 shares were automatically withheld at a price of $47.98 per share to cover tax obligations, leaving her with 7,470 common shares held directly after the transactions. Each restricted stock unit represents a right to one Cognex common share, and the grant vests approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the March 15, 2024 grant date.